PATENT CLAIM ANALYSIS

Application Number: 16012468
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["514", "210210"]

Abstract:
A compound of Formula (I), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for the treatment of lysine (K)-specific demethylase 1A (LSD1)-mediated diseases or disorders: wherein R 1 , R 2 , R 3 , R 4 , and R 5  are as defined herein.

Claim (Index 2):
The compound of  claim 1 , or a pharmaceutically acceptable salt, wherein R 1  is selected from cyclobutyl, cyclopentyl, and cyclohexyl, wherein each of the cyclobutyl, cyclopentyl, and cyclohexyl is independently substituted with one group selected from \u2014OH, \u2014C(O)OR, \u2014SO 2 R\u2032, \u2014SO 2 NR 2 , \u2014NRSO 2 R\u2032, and \u2014CONR 2 .

Metadata:
- Claim Count in Document: 5.0
- Percentile: 94.0
- Lexical Diversity: 1.30612
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['16081543', '14977273', '15538348', '16311621', '16311575']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.774396338384038
- 35 USC 102 Novelty (BERT): 0.5573715526717727
- Combined Prediction Score: 0.7526938598128114
- Mean Citation Score: 363.655234
- Max Citation Score: 415.89038
- Similarity Product: 325.48222574955463

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test